Cargando…
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS)
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599848/ http://dx.doi.org/10.1186/1546-0096-13-S1-P185 |
| _version_ | 1782394330593361920 |
|---|---|
| author | Trieste, L Della Casa Alberighi, O Turchetti, G Pierotti, F Accame, L Lorenzoni, V Frenkel, J Gattorno, M Quartier, P Martini, A |
| author_facet | Trieste, L Della Casa Alberighi, O Turchetti, G Pierotti, F Accame, L Lorenzoni, V Frenkel, J Gattorno, M Quartier, P Martini, A |
| author_sort | Trieste, L |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4599848 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45998482015-10-13 Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) Trieste, L Della Casa Alberighi, O Turchetti, G Pierotti, F Accame, L Lorenzoni, V Frenkel, J Gattorno, M Quartier, P Martini, A Pediatr Rheumatol Online J Poster Presentation BioMed Central 2015-09-28 /pmc/articles/PMC4599848/ http://dx.doi.org/10.1186/1546-0096-13-S1-P185 Text en Copyright © 2015 Trieste et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Trieste, L Della Casa Alberighi, O Turchetti, G Pierotti, F Accame, L Lorenzoni, V Frenkel, J Gattorno, M Quartier, P Martini, A Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) |
| title | Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) |
| title_full | Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) |
| title_fullStr | Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) |
| title_full_unstemmed | Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) |
| title_short | Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) |
| title_sort | cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to cryopyrin associated periodic syndromes (caps) |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599848/ http://dx.doi.org/10.1186/1546-0096-13-S1-P185 |
| work_keys_str_mv | AT triestel costeffectivenessanalysisandpreventioneffectsofultraorphandrugsforrarediseasesaninsilicomodelappliedtocryopyrinassociatedperiodicsyndromescaps AT dellacasaalberighio costeffectivenessanalysisandpreventioneffectsofultraorphandrugsforrarediseasesaninsilicomodelappliedtocryopyrinassociatedperiodicsyndromescaps AT turchettig costeffectivenessanalysisandpreventioneffectsofultraorphandrugsforrarediseasesaninsilicomodelappliedtocryopyrinassociatedperiodicsyndromescaps AT pierottif costeffectivenessanalysisandpreventioneffectsofultraorphandrugsforrarediseasesaninsilicomodelappliedtocryopyrinassociatedperiodicsyndromescaps AT accamel costeffectivenessanalysisandpreventioneffectsofultraorphandrugsforrarediseasesaninsilicomodelappliedtocryopyrinassociatedperiodicsyndromescaps AT lorenzoniv costeffectivenessanalysisandpreventioneffectsofultraorphandrugsforrarediseasesaninsilicomodelappliedtocryopyrinassociatedperiodicsyndromescaps AT frenkelj costeffectivenessanalysisandpreventioneffectsofultraorphandrugsforrarediseasesaninsilicomodelappliedtocryopyrinassociatedperiodicsyndromescaps AT gattornom costeffectivenessanalysisandpreventioneffectsofultraorphandrugsforrarediseasesaninsilicomodelappliedtocryopyrinassociatedperiodicsyndromescaps AT quartierp costeffectivenessanalysisandpreventioneffectsofultraorphandrugsforrarediseasesaninsilicomodelappliedtocryopyrinassociatedperiodicsyndromescaps AT martinia costeffectivenessanalysisandpreventioneffectsofultraorphandrugsforrarediseasesaninsilicomodelappliedtocryopyrinassociatedperiodicsyndromescaps |